Federal Project Grant Award Summary

The University of Alabama at Birmingham received $788,356 in Project Grant funding from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded July 13, 2026, with completion targeted for March 31, 2030. This four-year ancillary study to the Coronary Artery Risk Development in Young Adults (CARDIA) study, titled CARDIA CKMovers (Associations of Movement and Sleep Behaviors Through the Cardiovascular-Kidney-Metabolic Stage Progression), will deliver gold-standard accelerometry assessments and related analytical services to characterize movement behaviors in approximately 3,103 study participants during their Year 40 in-person examination (scheduled for 2026–2027, when participants will be 59–71 years old).

The project will generate seven days of objective accelerometry data per participant to measure sedentary behavior, light-intensity physical activity, and moderate-to-vigorous-intensity physical activity, paired with existing longitudinal health data spanning 40 years from early adulthood. These products will advance understanding of cardiovascular-kidney-metabolic syndrome progression by capturing novel associations between movement behaviors and disease stage transitions in a diverse cohort of Black and White adults, with particular emphasis on light-intensity physical activity—a significant portion of daily activity that cannot be accurately measured through self-report alone.